These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1319869)

  • 1. Hepatobiliary elimination of temafloxacin.
    Sörgel F; Granneman GR; Mahr G; Kujath P; Fabian W; Nickel P
    Clin Pharmacokinet; 1992; 22 Suppl 1():33-42. PubMed ID: 1319869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and biliary elimination of temafloxacin in pigs.
    Jehl F; Bresler L; Koechlin C; Merle-Melet M; Didelot JP; Hazebroucq J
    J Antimicrob Chemother; 1992 Aug; 30(2):189-96. PubMed ID: 1328135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of temafloxacin into body tissues and fluids.
    Sörgel F
    Clin Pharmacokinet; 1992; 22 Suppl 1():57-63. PubMed ID: 1319872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
    Brogard JM; Koechlin C; Westphal JF; Blicklé JF; Dorner M; Jehl F
    Drugs Exp Clin Res; 1990; 16(8):407-16. PubMed ID: 2097145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on the hepatobiliary kinetics and excretion of temafloxacin. Evidence for production of active metabolites by the rabbit liver].
    Brogard JM; Westphal JF; Koechlin C; Jehl F; Dorner M; Blickle JF; Monteil H
    Pathol Biol (Paris); 1991 May; 39(5):524-9. PubMed ID: 1881688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative bioavailability of temafloxacin administered through a nasogastric tube with and without enteral feeding.
    Lubowski TJ; Nightingale CH; Sweeney K; Quintiliani R
    Clin Pharmacokinet; 1992; 22 Suppl 1():43-7. PubMed ID: 1319870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of temafloxacin after multiple oral administration.
    Granneman GR
    Clin Pharmacokinet; 1992; 22 Suppl 1():14-23. PubMed ID: 1319867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of temafloxacin in patients with liver impairment.
    Granneman GR; Mahr G; Locke C; Nickel P; Kirch W; Fabian W; Kinzig M; Naber KG; Sörgel F
    Clin Pharmacokinet; 1992; 22 Suppl 1():24-32. PubMed ID: 1319868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the pharmacokinetic profile of temafloxacin.
    Dudley MN
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():55-64. PubMed ID: 1664830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cimetidine on the pharmacokinetics of temafloxacin.
    Sörgel F; Granneman GR; Stephan U; Locke C
    Clin Pharmacokinet; 1992; 22 Suppl 1():75-82. PubMed ID: 1319874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
    Vincent J; Teng R; Dalvie DK; Friedman HL
    Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of age on the pharmacokinetics of temafloxacin.
    Granneman GR; Guay DR
    Am J Med; 1991 Dec; 91(6A):71S-75S. PubMed ID: 1662898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of rufloxacin in humans.
    Privitera G; Nicastro G; Imbimbo BP; Cesana M; Visconti M; Lombardi F; Tagliabue G; Faleschini E; Colturani F; Franzini P
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2545-9. PubMed ID: 8109915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antacid medication on the pharmacokinetics of temafloxacin.
    Granneman GR; Stephan U; Birner B; Sörgel F; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():83-9. PubMed ID: 1319875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of temafloxacin in humans after multiple oral doses.
    Granneman GR; Carpentier P; Morrison PJ; Pernet AG
    Antimicrob Agents Chemother; 1992 Feb; 36(2):378-86. PubMed ID: 1318680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of temafloxacin in humans after single oral doses.
    Granneman GR; Carpentier P; Morrison PJ; Pernet AG
    Antimicrob Agents Chemother; 1991 Mar; 35(3):436-41. PubMed ID: 2039194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of food on the bioavailability of temafloxacin. A review of 3 studies.
    Granneman GR; Mukherjee D
    Clin Pharmacokinet; 1992; 22 Suppl 1():48-56. PubMed ID: 1319871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
    Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
    Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
    Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.